Clinical Trials
2
Active:2
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)TISSIUM™ Atraumatic Hernia Repair System (TAHRS) Pilot Study
Not Applicable
Active, not recruiting
- Conditions
- Hernia
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Tissium
- Target Recruit Count
- 78
- Registration Number
- NCT06042205
- Locations
- 🇧🇪
Ziekenhuis Oost-Limburg [ZOL], Genk, Limburg, Belgium
🇧🇪Imelda Hospital, Bonheiden, Belgium
🇧🇪AZ Sint-Jan, Ruddershove, Belgium
TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial
Not Applicable
Active, not recruiting
- Conditions
- Digital Nerve Injury
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Tissium
- Target Recruit Count
- 12
- Registration Number
- NCT04327154
- Locations
- 🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia
🇦🇺Gold Coast University Hospital, Gold Coast, Queensland, Australia
News
TISSIUM Receives FDA De Novo Authorization for First Atraumatic Sutureless Peripheral Nerve Repair System
TISSIUM's COAPTIUM® CONNECT with TISSIUM Light has received FDA De Novo marketing authorization, becoming the first and only FDA-authorized system designed for atraumatic sutureless nerve coaptation.